Jeffrey Basile Concurrent Technologies C Temple, TX - 76502

Jeffrey Basile Concurrent Technologies C is categorized under Research and Development Laboratories in Temple, TX and active since 2004.

Jeffrey Basile Concurrent Technologies C was established in 2004, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 1201 Larkspur Lane, Temple, Texas TX 76502 or by phoning (203) 562-5247. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Jeffrey Basile Concurrent Technologies C
Address: 1201 Larkspur Lane, Temple, Texas 76502
Phone Number: (203) 562-5247
Annual Revenue (USD): $0 to $49.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Jeffrey Basile Concurrent Technologies C was started in 2004 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.

Feel free to contact for inquiries that concern Jeffrey Basile Concurrent Technologies C by calling the company number (203) 562-5247, as your correspondence is most welcome. Additionally, the physical location of the single location of Jeffrey Basile Concurrent Technologies C can be found at the coordinates as well as the street address 1201 Larkspur Lane in Temple, Texas 76502.

For its online presence, you may visit Jeffrey Basile Concurrent Technologies C’s website at and engage with its social media outlets through on Twitter and on Facebook.